Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Chinese Agency Approves Image-Guided Radiotherapy System

By HospiMedica International staff writers
Posted on 10 May 2011
A fully integrated, image-guided radiotherapy system has been designed to treat tumors with great speed and accuracy--including tumors that move during treatment as the patient breathes in and out.

Varian Medical Systems, Inc. More...
(Palo Alto, CA, USA), a manufacturer of medical technology for treating cancer with radiotherapy, reported that the Chinese State Food and Drug Administration (SFDA) has approved its TrueBeam system for image-guided radiotherapy.

TrueBeam features many technical innovations that greatly synchronize imaging, patient positioning, motion management, and treatment delivery. With its high-intensity mode, TrueBeam can deliver very high doses rapidly and accurately, more than twice as fast as earlier generations of technology. This makes it possible to considerably shorten treatments, and to improve precision by leaving less time for tumor motion during dose delivery. It also enables clinics to offer advanced treatment to more cancer patients each day.

"Intelligent" automation further speeds treatments and makes the technology easier to use, with an up to five-fold reduction in the number of steps needed for imaging, positioning and treating patients. A standard intensity-modulated treatment that would typically take 10 minutes can be completed in less than two minutes.

Varian first introduced the TrueBeam system in the United States in April 2010. It is now in use at more than 40 treatment centers across the United States and Europe to target tumors of the lung, liver, pancreas, head and neck, and many other organs. "The TrueBeam system is Varian's most advanced offering for dealing with tumor motion, which makes it especially well-suited for treating cancer of the lung and liver, two types that occur commonly in China," said Tom Duffy, head of Varian's oncology systems business in Asia. "With its combination of advanced real-time imaging, high-intensity mode, and gated RapidArc for synchronizing treatment with tumor motion, it's an excellent device for delivering high-dose hypofractionated radiotherapy. There is a growing body of research that indicates this is an especially effective way to treat liver and lung cancer."

Related Links:

Varian Medical Systems




Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Ultrasound System
FUTUS LE
Isolation Stretcher
IS 736
PACS Workstation
PaxeraView PRO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.